Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05980793

Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS), a Randomized Controlled Trial

Led by Karolinska Institutet · Updated on 2024-12-02

90

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

K

Karolinska Institutet

Lead Sponsor

S

Stockholm South General Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to compare surgical and non-surgical treatments in adults with osteoarthritis affecting the proximal interphalangeal (PIP) joint of the finger. The study evaluates whether these treatments reduce pain, improve patient-reported function, quality of life, movement, and grip strength. Researchers want to find out if surgical denervation is more effective than patient education combined with exercise for this condition. Participants will be randomly assigned to one of two groups: one receiving surgical denervation of the PIP joint performed through a volar approach, and the other undergoing a program of patient education plus exercise. The study uses a two-arm parallel design with block randomization and stratification by gender. The treatments and outcomes will be compared over a 12-month period. Participants will be assessed at the start, and then at 3, 6, and 12 months after treatment. Evaluations include measuring pain during load, pain at rest, patient questionnaires about wrist and hand function, quality of life surveys, and objective function tests. Researchers will also monitor complications and any additional treatments during the year. The primary outcome is the change in pain on load from baseline to 12 months.

CONDITIONS

Brief Title

Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 2 18 years
  • Chronic symptomatic osteoarthritis in the PIP-joint
  • Radiological signs of osteoarthritis on posteroanterior and lateral radiographs assessed by the Kellgren-Lawrence classification (grade II-IV)
  • Clinical signs of PIP-joint arthritis
Not Eligible

You will not qualify if you...

  • Inflammatory arthritis
  • Ongoing infection in the hand
  • Inability to co-operate with the follow-up protocol
  • Intra-articular glucocorticoid, PRP or Hyaluronic acid injections in the affected joint less than 3 months prior to enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - 12 months

Participants receive either surgical denervation of the PIP joint or participate in an education plus exercise program to manage osteoarthritis symptoms.

1 baseline visit and 3 follow-up visits at 3, 6, and 12 months

Trial Site Locations

Total: 1 location

1

Department of Hand Surgery, Södersjukhuset

Stockholm, Sweden

Actively Recruiting

Loading map...

Research Team

E

Elin Sward, MD, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Clinical Outcomes of Indocyanine Green Tracer in 3D Plus Ult...

Gastric Cancer

Actively Recruiting

1 location

Evaluating the Clinical Value of 68Ga-TCR-FAPI PET/CT to Gui...

Medullary Thyroid Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Efficacy of denervation for osteoarthritis in the proximal interphalangeal joint (DOP): protocol of a randomized controlled trial.

Elin M Swärd, Jonas Beckman, Farnoush Tabaroj...

https://pubmed.ncbi.nlm.nih.gov/39169395